Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 160

Dropbox starts IPO preparations

The Salesforce Ventures-backed data storage platform is reportedly seeking underwriters for what could be the largest tech IPO since Snap.

Jul 4, 2017

Razer aims for $600m in Hong Kong IPO

The gaming product and software provider is set to float in Asia, giving an exit to investors including Hangzhou Liaison Interactive.

Jul 3, 2017

Delivery Hero triumphs in $1.1bn IPO

The Rocket Internet-owned Global Online Takeaway Group sold some $148m in shares, as the online food ordering platform floated at the top of its range.

Jul 3, 2017

ZhongAn sets up $1.5bn Hong Kong IPO

Ping An, Tencent and the Alibaba-affiliated Ant Financial jointly own 40% of the online insurance platform, and are set to exit in an offering that could take place this year.

Jun 30, 2017

Mersana makes $75m in IPO

The cancer drug conjugate developer floated in the middle of its range, in an offering that provided exits to Takeda subsidiary Millennium Pharmaceuticals and Pfizer.

Jun 29, 2017

Alibaba to exit in Best IPO

Alibaba is the largest shareholder of logistics and supply chain services provider Best, which has filed for a $750m initial public offering, after raising more than $910m in VC funding.

Jun 27, 2017

Shotspotter shoots to IPO

The gunfire detection technology provider floated in the middle of its range in a $30.8m IPO that gave an exit to Motorola Solutions Venture Capital.

Jun 8, 2017

Aileron to align itself with public markets

Stapled peptide developer Aileron Therapeutics has filed for a $69m IPO that will allow Roche, Novartis, GlaxoSmithKline and Eli Lilly to exit.

Jun 7, 2017

Delivery Hero gets set for IPO

Delivery Hero plans to issue almost $510m of shares in Germany and Luxembourg, while its largest shareholder, Rocket Internet, could sell the same number.

Jun 7, 2017

Mersana swerves to public markets

The Pfizer and Takeda-backed breast cancer therapy developer has filed to raise $75m in an initial public offering that follows some $130m in equity financing.

Jun 6, 2017
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here